infectious disease rapid diagnostic test / for sexually transmitted diseases / Mycoplasma / Ureaplasma parvum
RIDA® PG4945



  • Applications:

    for infectious diseases, for sexually transmitted diseases

  • Tested parameter:

    Mycoplasma, Ureaplasma parvum, Ureaplasma urealyticum

  • Sample type:



Intended use:
For in-vitro diagnostic use. RIDA®GENE STI Mycoplasma Panel is a real-time PCR for the direct, qualitative detection of Mycoplasma hominis, Mycoplasma genitalium and Ureaplasma urealyticum/parvum from human genital swabs and urine.

General Information:
Mycoplasma species may persist as part of the normal human flora of the respiratory system or the genital area. Of seven known mycoplasma species from the genital area, so far only four have been described as pathogenic: Mycoplasma hominis, Mycoplasma genitalium, Ureaplasma urealyticum und Ureaplasma parvum.

Mycoplasma hominis (M. hominis) mainly colonizes the genital tract of sexually active men and women, however most of the M. hominis described infections have been diagnosed in woman. M. hominis is associated with pelvic inflammatory disease (PID) and may cause infections during or after pregnancy, such as endometritis or neonatal pneumonia. Common symptoms for infections with M. hominis include e.g. frequent urination, yellow discharge or dysuria.

Globally, the prevalence of Mycoplasma genitalium (M. genitalium) ranges between 1- 4 % for men and 1 – 6.4 % for women. In men, M. genitalium may result in non-specific urethritis and is the second most common cause after Chlamydia trachomatis. About 30 % of persistent urethritis is linked to M. genitalium. In women, M. genitalium infections may lead to cervicitis, endometritis, urethritis or pelvic inflammatory disease (PID).

Other R-Biopharm products